Pages that link to "Q38944133"
Jump to navigation
Jump to search
The following pages link to A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens (Q38944133):
Displaying 12 items.
- A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates (Q27116692) (← links)
- Co-Administration of Lipid Nanoparticles and Sub-Unit Vaccine Antigens Is Required for Increase in Antigen-Specific Immune Responses in Mice (Q37539243) (← links)
- EDIII-DENV3 nanospheres drive immature dendritic cells into a mature phenotype in an in vitro model (Q38730891) (← links)
- Future of human Chlamydia vaccine: Potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles (Q47643650) (← links)
- Growth hormone releasing peptide-6 enhanced antibody titers against subunit antigens in mice (BALB/c), tilapia (Oreochromis niloticus) and African catfish (Clarias gariepinus). (Q47688202) (← links)
- Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections (Q50335281) (← links)
- Cross-presentation of lactoferrin encapsulated into chitosan-based nanoparticles. (Q55268838) (← links)
- The promise of mRNA vaccines: a biotech and industrial perspective (Q84957958) (← links)
- Single-Molecule Resolution of Antimicrobial Peptide Interactions with Supported Lipid A Bilayers (Q89011249) (← links)
- Advancements in Prophylactic and Therapeutic Nanovaccines (Q91731105) (← links)
- Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants (Q92462186) (← links)
- A systematic review of SARS-CoV-2 vaccine candidates (Q100533622) (← links)